Epidural spinal cord stimulation to help breathing after cervical spinal cord injury
Official title: An Exploratory Clinical Trial of Cervical Epidural Spinal Cord Stimulation for Respiratory Recovery in Patients With Cervical Spinal Cord Injury
Run by Zhongda Hospital · NCT07722130 · Data updated 2026-11-12
This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Zhongda Hospital Academic / other |
| Locations | 2 sites (Nanjing, Jiangsu and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | March 31, 2029 |
| Registry record updated | September 4, 2026 |
| Trial ID | NCT07722130 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-75 with C1-C5 SCI for at least 2 weeks and respiratory failure who can be safely implanted with an epidural stimulator.
✕Probably not a fit
Patients without adequate device tolerance, with active infection at implant site, or whose respiratory failure is primarily due to non-SCI conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, single-arm study enrolls 20 adults with C1-C5 spinal cord injury and respiratory failure to receive epidural spinal cord stimulation implanted over the C3-C5 region, with daily tailored stimulation in addition to standard care. Primary outcomes focus on diaphragm electrical activity (Edi) and its changes, while secondary measures include lung volumes, diaphragm function on ultrasound, cough strength, ventilator-free days, ICU stay, and survival. The trial aims to establish preliminary safety and signals of efficacy to support future randomized studies. Conducted at two Chinese centers, it is investigator-initiated and the first systematic ESCES evaluation for SCI-related respiratory failure.
Why it matters
Potential benefit: If successful, ESCES could improve diaphragm activity and help wean patients from mechanical ventilation.
How similar studies have gone: Previous work in this area is limited; this is the first systematic ESCES study in SCI-related respiratory failure, with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 and 75 years, with BMI \<30 kg/m². 2. Cervical SCI involving levels C1-C5 for at least 2 weeks. 3. Respiratory failure defined by one or more of the following: * Peripheral oxygen saturation \<90% on room air; * Arterial oxygen tension (PaO₂) \<60 mmHg; * Respiratory acidosis (PaCO₂ \>45 mmHg with pH \<7.35); * Requirement for mechanical ventilation. 4. Maximum inspiratory pressure (MIP) \>-15 cmH₂O. 5. Judged by the treating physician to be unable to tolerate continuous ventilator weaning for ≥48 hours due to SCI. 6. Written informed consent provided by the participant or legally authorized representative. Exclusion Criteria: 1. Active infection at the planned electrode implantation site, severe systemic infection, or existing implanted neurostimulation devices. 2. Respiratory failure primarily caused by severe pneumonia, pulmonary contusion, pneumothorax, hemothorax, chronic obstructive pulmonary disease, or requirement for home oxygen therapy within the previous 6 months. 3. New York Heart Association (NYHA) class III or IV heart failure or implanted cardiac pacemaker. 4. Severe hepatic or renal dysfunction (Child-Pugh class C liver disease or estimated glomerular filtration rate ≤30 mL/min/1.73 m²) or dialysis dependence. 5. Generalized seizures, traumatic brain injury, intracranial hypertension, intracranial aneurysm with Glasgow Coma Scale score ≤12, or neuromuscular disorders affecting respiratory function. 6. Expected survival \<72 hours or refusal of life-sustaining treatment. 7. Pregnancy or breastfeeding. 8. Any other condition considered by the investigator to make study participation inappropriate.
Where it's running
-
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China Recruiting -
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Fei Peng, Dr. PhD.
- Email: afei0312@163.com
- Phone: 15950565786
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Electrical stimulation for arm function after cervical spinal cord injury in veterans
In veterans with a recent cervical spinal cord injury, researchers are testing whether transcutaneous spinal stimulation (TSS) can improve arm and hand function more than the standard functional electrical stimulation (FES) during inpatient rehab.
-
HFNC During Bronchoscopy for Respiratory Failure
This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Wireless implant for brain-computer interface in people with tetraplegia from spinal cord injury
This trial tests a wireless brain-computer interface implanted in adults with tetraplegia to see if it is safe and if it can help restore some function.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Ciprofol versus propofol for sedating adult ICU patients on noninvasive respiratory support
See if ciprofol works better than propofol for sedating adults in the ICU who are receiving noninvasive ventilation, high-flow nasal cannula, or oxygen therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.